SCHEMBL5638102

SCHEMBL5638102

C[Sn](C)(C)c1c(C(F)(F)F)cccc1C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.39
P2RX7 Q99572 1/20 0.38
ALDH1A1 P00352 5/20 0.35
POLB P06746 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
HSD11B1 P28845 2/20 0.35
AXL P30530 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
PARP1 P09874 1/20 0.35
CES1 P23141 1/20 0.34
HSD17B10 Q99714 2/20 0.33
CA2 P00918 1/20 0.33
IDO1 P14902 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8166939 0.73 ALDH1A1 (0.39) KIF11P2RX7ALDH1A1POLBL3MBTL1
SCHEMBL6630838 0.70 TAS2R14 (0.46) KIF11P2RX7ALDH1A1POLBL3MBTL1
SCHEMBL29441997 0.68 ALDH1A1 (0.52) KIF11ALDH1A1POLBL3MBTL1TDP1
SCHEMBL63469 0.68 ALDH1A1 (0.52) KIF11ALDH1A1POLBL3MBTL1TDP1
SCHEMBL2000756 0.67 HSD11B1 (0.46) KIF11P2RX7ALDH1A1POLBL3MBTL1
SCHEMBL7601747 0.67 MPL (0.46) KIF11P2RX7ALDH1A1POLBL3MBTL1
SCHEMBL8728398 0.67 ALDH1A1 (0.41) KIF11P2RX7ALDH1A1POLBL3MBTL1
SCHEMBL807279 0.67 P2RX7 (0.48) KIF11P2RX7ALDH1A1POLBL3MBTL1
SCHEMBL8225343 0.67 CA2 (0.44) KIF11P2RX7ALDH1A1POLBL3MBTL1
SCHEMBL19267580 0.67 HSD11B1 (0.42) KIF11P2RX7ALDH1A1POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39679-E1 Substituted heterocycle fused gamma-carbolines BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-06-05 US disclosed
US-7038070-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2006-05-02 US disclosed
US-6963017-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2005-11-08 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-6713471-B1 SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-03-30 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A KIF11 2978/4885P2RX7 3628/4885ALDH1A1 317/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 KIF11 2913/4885P2RX7 3663/4885ALDH1A1 198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.